The FDA has pushed back its review of Moderna's RSV vaccine owing to administrative issues.
Though the flu season is winding down, the CDC received 10 more reports of pediatric flu deaths, including one from a flu A/flu B coinfection.
Amid further declines in COVID activity, the CDC reported a steady rise in JN.1 spinoffs that have 2 added spike mutations, part of a group nicknamed FLiRT.
Overall, 40% percent of respondents perceived that RSV illness among children is both serious and likely.
In 2021 and 2022, the virus appeared to peak early in several states and to cause more severe illness.
Wastewater COVID detections declined to the minimal level and are highest in the Midwest.
The return on investment of up to $4,637 per vaccination course translates to billions of dollars in net monetary benefits to society, the authors say.
Moreover, 1 in 12 of infected patients (8.5%) had no documented underlying cardiovascular disease.
Outpatient visits for flulike illness is below the national baseline for the first time since October.
The company said it will submit data to regulatory agencies for potential approval in adults ages 18 and older.